100% satisfaction guarantee Immediately available after payment Both online and in PDF No strings attached
logo-home
Samenvatting boek 1 farmacologie geneeskunde $10.33   Add to cart

Summary

Samenvatting boek 1 farmacologie geneeskunde

1 review
 154 views  1 purchase
  • Course
  • Institution

Volledige samenvatting boek 1 farmacologie 3e bachelor geneeskunde met extra notities uit de les.

Preview 5 out of 71  pages

  • February 2, 2023
  • 71
  • 2021/2022
  • Summary

1  review

review-writer-avatar

By: paulinedhollander • 1 year ago

avatar-seller
,Inhoud


Inleiding & terminologie .................................................................................................................................. 1

1. Absorptie: transport van farmaca over biologische membranen ................................................................. 2
1.1. Mechanismen bij de opname van stoffen over biologische membranen ............................................... 3
1.2. Mechanismen die de opname van stoffen over membranen beïnvloeden ............................................ 5
1.3. Opname vanuit het gastro-intestinaalstelsel: interfererende factoren .................................................. 7

2. Verdeling of distributie .............................................................................................................................. 11
2.1. Distributievolume .................................................................................................................................. 11
2.2. Waarvan is het distributievolume afhankelijk? ................................................................................ 12
2.3. Enkele bijzondere weefsels met betrekking tot distributie ................................................................... 14

3. Eliminatie ................................................................................................................................................... 16
3.1. Biotransformatie .................................................................................................................................... 16
3.2. Renale klaring ........................................................................................................................................ 23
3.3. Andere excretiewegen ........................................................................................................................... 25

4. Farmacokinetiek ........................................................................................................................................ 27
4.1. Eenmalige intraveneuze toediening ...................................................................................................... 28
4.2. Eenmalige extra-vasculaire toediening .................................................................................................. 31
4.3. Herhaalde toediening ............................................................................................................................ 34
4.4. Continu intraveneus infuus.................................................................................................................... 35
4.5. Het doseringsschema en het therapeutisch venster ............................................................................. 36
4.6. Plasmaspiegelbepalingen ...................................................................................................................... 37
4.7. Niet-lineaire kinetiek ............................................................................................................................. 40
4.8. Stereoselectieve farmacokinetiek ......................................................................................................... 41

5. Farmacodynamiek ..................................................................................................................................... 42
5.1. Farmacologische effecten op moleculair niveau ................................................................................... 42
5.2. Farmacologische effecten op orgaan niveau: de concentratie-effect curve ......................................... 44
5.3. Farmacologische effecten in een organisme of populatie: de dosis-effect curve ................................. 47

6. Toedieningsvormen ................................................................................................................................... 53
6.1. Enterale inname..................................................................................................................................... 53
6.2. Parenteraal ............................................................................................................................................ 56

7. Farmacotherapie bij risicopopulaties ......................................................................................................... 58
7.1. Farmacotherapie bij extreme leeftijden ................................................................................................ 58
7.2. Farmacotherapie tijdens conceptie, zwangerschap en borstvoeding .............................................. 60
7.3. Farmacotherapie en co-morbiditeit ...................................................................................................... 64

8. Acute intoxicaties ...................................................................................................................................... 67
8.1. Algemene principes ............................................................................................................................... 67
8.2. Ondersteunende therapie ..................................................................................................................... 68
8.3. Verwijderen van nog niet geabsorbeerde stof ...................................................................................... 69
8.4. Versnellen van de eliminatie ................................................................................................................. 71
8.5. Identificatie van het oorzakelijk toxine ................................................................................................. 72
8.6. Specifieke antidota ................................................................................................................................ 73

, 8.7. De comateuze patiënt ........................................................................................................................... 74

APPENDIX A ................................................................................................................................................... 76

Ontdekking, ontwikkeling en evaluatie van nieuwe geneesmiddelen ............................................................ 76

APPENDIX B ................................................................................................................................................... 80

Naamgeving van geneesmiddelen ................................................................................................................. 80

APPENDIX C ................................................................................................................................................... 81

Het informeren van de patiënt ...................................................................................................................... 81

APPENDIX D ................................................................................................................................................... 84

Het medisch voorschrift voor ambulante patiënten....................................................................................... 84

APPENDIX E ................................................................................................................................................... 94

Regelgevende aspecten, inclusief farmacovigilantie ...................................................................................... 94

APPENDIX F ................................................................................................................................................... 94

Farmacologische aspecten van antibioticagebruik ......................................................................................... 94

,
,

The benefits of buying summaries with Stuvia:

Guaranteed quality through customer reviews

Guaranteed quality through customer reviews

Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.

Quick and easy check-out

Quick and easy check-out

You can quickly pay through credit card or Stuvia-credit for the summaries. There is no membership needed.

Focus on what matters

Focus on what matters

Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!

Frequently asked questions

What do I get when I buy this document?

You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.

Satisfaction guarantee: how does it work?

Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.

Who am I buying these notes from?

Stuvia is a marketplace, so you are not buying this document from us, but from seller Gnkkuleuven. Stuvia facilitates payment to the seller.

Will I be stuck with a subscription?

No, you only buy these notes for $10.33. You're not tied to anything after your purchase.

Can Stuvia be trusted?

4.6 stars on Google & Trustpilot (+1000 reviews)

64438 documents were sold in the last 30 days

Founded in 2010, the go-to place to buy study notes for 14 years now

Start selling
$10.33  1x  sold
  • (1)
  Add to cart